Effects of Androgen Treatment on Growth in Patients with 5-α-Reductase Type 2 Deficiency.

DHT treatment is more favorable for height than TE treatment in patients with 5αRD2, particularly during the prepubertal period. Therefore, age and the type of androgen used should be carefully considered to minimize the risk of height reduction in these patient groups.